Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rheumatic Heart Disease | 5 | 2021 | 177 | 1.140 |
Why?
|
| Haiti | 7 | 2023 | 553 | 0.870 |
Why?
|
| Hospitals, District | 5 | 2019 | 106 | 0.730 |
Why?
|
| Cardiomyopathies | 4 | 2023 | 1913 | 0.710 |
Why?
|
| Heart Failure | 8 | 2023 | 10905 | 0.640 |
Why?
|
| Rural Population | 5 | 2020 | 2210 | 0.590 |
Why?
|
| Poverty | 10 | 2021 | 2660 | 0.550 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2016 | 392 | 0.460 |
Why?
|
| Emergency Medicine | 1 | 2022 | 1207 | 0.430 |
Why?
|
| Developing Countries | 5 | 2022 | 2814 | 0.430 |
Why?
|
| Health Services Accessibility | 4 | 2023 | 5138 | 0.330 |
Why?
|
| Hypertension | 3 | 2024 | 8480 | 0.310 |
Why?
|
| Curriculum | 1 | 2021 | 3604 | 0.310 |
Why?
|
| Morbidity | 5 | 2020 | 1769 | 0.300 |
Why?
|
| Health Care Costs | 1 | 2020 | 3209 | 0.280 |
Why?
|
| Cost of Illness | 4 | 2021 | 1859 | 0.270 |
Why?
|
| Malawi | 2 | 2023 | 282 | 0.250 |
Why?
|
| Endemic Diseases | 2 | 2016 | 182 | 0.250 |
Why?
|
| Rwanda | 5 | 2020 | 703 | 0.230 |
Why?
|
| Internship and Residency | 1 | 2022 | 5787 | 0.200 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 15161 | 0.190 |
Why?
|
| Nutrition Disorders | 1 | 2021 | 211 | 0.190 |
Why?
|
| Chest Pain | 1 | 2007 | 1114 | 0.180 |
Why?
|
| Investments | 1 | 2021 | 143 | 0.170 |
Why?
|
| Serine Proteinase Inhibitors | 3 | 2005 | 179 | 0.170 |
Why?
|
| Africa South of the Sahara | 3 | 2020 | 724 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 1573 | 0.160 |
Why?
|
| Health Facilities | 1 | 2023 | 573 | 0.160 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 7784 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2018 | 941 | 0.160 |
Why?
|
| Nurse's Role | 1 | 2018 | 209 | 0.140 |
Why?
|
| Hospitalization | 1 | 2016 | 10262 | 0.140 |
Why?
|
| Humans | 36 | 2024 | 744220 | 0.130 |
Why?
|
| Nursing Staff, Hospital | 1 | 2018 | 346 | 0.130 |
Why?
|
| Rural Health Services | 1 | 2018 | 379 | 0.130 |
Why?
|
| Internal Medicine | 1 | 2022 | 1009 | 0.130 |
Why?
|
| Subtilisins | 2 | 2005 | 83 | 0.130 |
Why?
|
| Retrospective Studies | 8 | 2023 | 77426 | 0.120 |
Why?
|
| Echocardiography, Doppler | 1 | 2018 | 934 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5096 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 3533 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6489 | 0.100 |
Why?
|
| Male | 16 | 2023 | 350027 | 0.100 |
Why?
|
| Female | 18 | 2023 | 380197 | 0.100 |
Why?
|
| Maternal Mortality | 1 | 2014 | 310 | 0.100 |
Why?
|
| Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 126 | 0.090 |
Why?
|
| Life Expectancy | 1 | 2017 | 1184 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 850 | 0.090 |
Why?
|
| Forecasting | 1 | 2018 | 2949 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 658 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2022 | 6442 | 0.080 |
Why?
|
| Risk Factors | 8 | 2020 | 72280 | 0.080 |
Why?
|
| Adult | 9 | 2023 | 214035 | 0.080 |
Why?
|
| Middle Aged | 7 | 2023 | 213367 | 0.080 |
Why?
|
| Peptides | 3 | 2005 | 4407 | 0.080 |
Why?
|
| Hydrogen Bonding | 2 | 2005 | 293 | 0.080 |
Why?
|
| Income | 1 | 2016 | 1913 | 0.080 |
Why?
|
| Occupational Diseases | 1 | 2015 | 1472 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2022 | 4687 | 0.070 |
Why?
|
| Social Class | 1 | 2015 | 1999 | 0.070 |
Why?
|
| Natriuretic Peptides | 1 | 2007 | 150 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 25043 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5755 | 0.060 |
Why?
|
| Chymotrypsin | 1 | 2004 | 149 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2005 | 1724 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1797 | 0.060 |
Why?
|
| Malaria | 1 | 2014 | 1239 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5319 | 0.060 |
Why?
|
| Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4645 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4463 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2017 | 23337 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39045 | 0.050 |
Why?
|
| Overweight | 1 | 2014 | 2370 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3132 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2007 | 926 | 0.050 |
Why?
|
| Length of Stay | 1 | 2016 | 6308 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
| Organizational Objectives | 2 | 2014 | 438 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5316 | 0.050 |
Why?
|
| Prevalence | 5 | 2017 | 15226 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2014 | 1912 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 11728 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1536 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2886 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2012 | 1188 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4236 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2016 | 4256 | 0.050 |
Why?
|
| Asia, Southeastern | 1 | 2020 | 111 | 0.050 |
Why?
|
| HIV Infections | 3 | 2016 | 16718 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2012 | 2895 | 0.050 |
Why?
|
| Echocardiography | 1 | 2013 | 5103 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2017 | 2297 | 0.050 |
Why?
|
| Aged | 4 | 2023 | 163253 | 0.050 |
Why?
|
| Senegal | 1 | 2020 | 294 | 0.040 |
Why?
|
| Smoking | 1 | 2016 | 8986 | 0.040 |
Why?
|
| Nepal | 1 | 2020 | 295 | 0.040 |
Why?
|
| Hospitals, Public | 1 | 2020 | 207 | 0.040 |
Why?
|
| ROC Curve | 1 | 2007 | 3527 | 0.040 |
Why?
|
| Africa | 1 | 2021 | 673 | 0.040 |
Why?
|
| Hydrolysis | 3 | 2005 | 682 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2012 | 5008 | 0.040 |
Why?
|
| Bangladesh | 1 | 2020 | 687 | 0.040 |
Why?
|
| Ethiopia | 1 | 2020 | 495 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2023 | 645 | 0.040 |
Why?
|
| Age Distribution | 2 | 2014 | 2903 | 0.040 |
Why?
|
| Plant Proteins | 3 | 2005 | 364 | 0.040 |
Why?
|
| Politics | 1 | 2024 | 791 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15070 | 0.040 |
Why?
|
| Stroke | 2 | 2016 | 9981 | 0.040 |
Why?
|
| Uganda | 1 | 2021 | 1243 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 11732 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3528 | 0.030 |
Why?
|
| Acute Disease | 1 | 2007 | 7148 | 0.030 |
Why?
|
| Tanzania | 1 | 2020 | 1346 | 0.030 |
Why?
|
| Models, Theoretical | 2 | 2021 | 3591 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 5034 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5615 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 4586 | 0.030 |
Why?
|
| Cause of Death | 2 | 2017 | 3584 | 0.030 |
Why?
|
| Sanitation | 1 | 2015 | 93 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2021 | 1531 | 0.030 |
Why?
|
| Crystallization | 2 | 2005 | 524 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2021 | 1167 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12781 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2016 | 657 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2020 | 5102 | 0.030 |
Why?
|
| Methionine | 2 | 2005 | 590 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 40063 | 0.030 |
Why?
|
| Obesity | 1 | 2014 | 12742 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14726 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2005 | 2012 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2018 | 2486 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15538 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2021 | 2348 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 523 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 5396 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 35129 | 0.020 |
Why?
|
| Pregnancy | 2 | 2023 | 29142 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 56436 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 7659 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 40992 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2018 | 2529 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2015 | 1609 | 0.020 |
Why?
|
| Child | 3 | 2023 | 77679 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6485 | 0.020 |
Why?
|
| Hordeum | 1 | 2005 | 20 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2015 | 1796 | 0.020 |
Why?
|
| Adolescent | 3 | 2018 | 85759 | 0.020 |
Why?
|
| Bacillus | 1 | 2005 | 77 | 0.020 |
Why?
|
| Acylation | 1 | 2004 | 107 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 8090 | 0.020 |
Why?
|
| Threonine | 1 | 2005 | 279 | 0.020 |
Why?
|
| Disease Management | 1 | 2015 | 2458 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6461 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2007 | 40559 | 0.010 |
Why?
|
| Static Electricity | 1 | 2004 | 267 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6612 | 0.010 |
Why?
|
| Solvents | 1 | 2005 | 302 | 0.010 |
Why?
|
| Health Behavior | 1 | 2015 | 2636 | 0.010 |
Why?
|
| Mortality | 1 | 2014 | 2864 | 0.010 |
Why?
|
| Protein Binding | 2 | 2005 | 9392 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 2026 | 0.010 |
Why?
|
| Surface Properties | 1 | 2004 | 1184 | 0.010 |
Why?
|
| Arginine | 1 | 2005 | 944 | 0.010 |
Why?
|
| Serine | 1 | 2005 | 828 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 503 | 0.010 |
Why?
|
| Glycine | 1 | 2004 | 671 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25618 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1801 | 0.010 |
Why?
|
| Insulin | 1 | 2015 | 6583 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8387 | 0.010 |
Why?
|
| Bacillus subtilis | 1 | 2003 | 359 | 0.010 |
Why?
|
| Lysine | 1 | 2004 | 1008 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2005 | 1169 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 3133 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29050 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 20945 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3846 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 6116 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 6474 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 2751 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 57768 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 5458 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53280 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2003 | 4220 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10949 | 0.010 |
Why?
|
| Proteins | 1 | 2003 | 6101 | 0.000 |
Why?
|
| Mutation | 1 | 2003 | 29784 | 0.000 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_